Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 14Recruiting 3Withdrawn 1Unknown 1Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 372Precursor Cell Lymphoblastic Leukemia-Lymphoma 292Leukemia 218Hematologic Neoplasms 160Leukemia, Lymphocytic, Chronic, B-Cell 129Lymphoma 107Myelodysplastic Syndromes 90Leukemia, Myelogenous, Chronic, BCR-ABL Positive 82Lymphoma, Non-Hodgkin 66Recurrence 63Lymphoma, Large B-Cell, Diffuse 50Lymphoma, Follicular 47Lymphoma, Mantle-Cell 44Multiple Myeloma 42Burkitt Lymphoma 41Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 39Leukemia, B-Cell 39Neoplasms 38Leukemia, Myeloid, Chronic-Phase 37Lymphoma, B-Cell 36Lymphoma, B-Cell, Marginal Zone 31Hodgkin Disease 29Lymphoma, Large-Cell, Immunoblastic 26Leukemia, Promyelocytic, Acute 23Leukemia, Myelomonocytic, Chronic 21Neoplasms, Plasma Cell 19Myeloproliferative Disorders 19Congenital Abnormalities 19Leukemia, Myelomonocytic, Acute 18Leukemia, Myeloid 18

Interventions

fludarabine phosphate 1fludarabine 1Melphalan 1Maintenance 1Dexamethasone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Chromosome 17 deletion × Other hematologic neoplasm × Clear all
NCT04008888 2019-07-05

a Clinical Trial of Efficacy and Safety of the Holistic Treatment of Young High-risk Multiple Myeloma Patients

Institute of Hematology & Blood Diseases Hospital, China

Phase NA Unknown
50 enrolled
Other hematologic neoplasmPlasma cell

Chromosome 17 deletion, Leukemia, Plasma Cell, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡